WWW.DISSERS.RU


...
    !

Pages:     | 1 | 2 ||

insonb [et al.] // Family Practice. 2009. Vol. 26. P. 180182.

32. Association between erythropoietin gene polymorphisms 13. The prevalence of anaemia in diabetes with stage and diabetic retinopathy / S. Abhary, K. P. Burdon, R. J. Casson [et chronic kidney disease: a retrospective analysis / U. y. Raja, al.] // Arch. Ophthalmol. 2010. Vol. 128, 1. P. 102106.

J. Chan, E. Radford [et al.] // The British Journal of Diabetes & 33. Expression of erythropoietin receptor in human epiretinal Vascular Disease. 2011. Vol. 11, 9. P. 259261.

membrane of proliferative diabetic retinopathy / S. Kase, W. Saito, 14. Artunc F., Risler T. Serum erythropoietin concentrations K. Ohgami [et al.] // Br. J. Ophthalmol. 2007. Vol. 91. P. 1376 and responses to anaemia in patients with or without chronic kid1378.

ney disease // Nephrol. Dial. Transplant. 2007. Vol. 22, 10. P.

34. Wang Z. y., Zhao K. K., Zhao P. q. Erythropoietin therapy 29002908.

for early diabetic retinopathy through its protective effects on reti15. Fantacci M., Bianciardi P., Caretti A. Carbamylated erythnal pericytes // Med. Hypotheses. 2011. Vol. 76, 2. P. 266268.

ropoietin ameliorates the metabolic stress induced in vivo by 35. EPO attenuates inflammatory cytokines by Muller cells severe chronic hypoxia // Proc. Natl. Acad. Sci. 2006. Vol. 103, in diabetic retinopathy / X. Lei, J. Zhang, J. Shen [et al.] // Front.

46. P. 1753117536.

Biosci. (Elite Ed). 2011. Vol. 3, 1. P. 201211.

16. Marsden J. T. Erythropoietin measurement and clinical 36. A hypothesis: can erythropoietin administration affect applications // Ann. Clin. Biochem. 2006. Vol. 43, 2. P. 97104.

the severity of retinopathy in diabetic patients with renal fail17. Singh D. K., Winocour P., Farrington K. Erythropoietic ure / C. J. Diskin, T. J. Stokes, L. M. Dansby [et al.] // Amer. J. Med.

stress and anemia in diabetes mellitus // Nat. Rev. Endocrinol.

Sci. 2007. Vol. 334, 10. P. 260264.

2009. Vol. 5, 4. P. 204210.

37. Anemia With Erythropoietin Deficiency Occurs Early in 18. Singh D. K., Winocour P., Farrington K. Mechanisms of Diabetic Nephropathy / D. R. Bosman, A. S. Winkler, J. T. Marsden disease: the hypoxic tubular hypothesis of diabetic nephropathy [et al.] // Diabetes Care. 2001. Vol. 24, 3. P. 495499.

// Nat. Clin. Pract. Nephrol. 2008. Vol. 4, 4. P. 216226.

38. Blunted erythropoietin response to anemia in patients 19. Adaptation to hypoxia in the diabetic rat kidney / C. Rosenwith Type I diabetes / P. Cotroneo, B. Maria Ricerca, L. Todaro [et berger, M. Khamaisi, Z. Abassi [et al.] // Kidney Int. 2008. Vol. 73, al.] // Diabetes Metab. Res. Rev. 2000. Vol. 16, 56. P. 172 1. P. 3442.

176.

20. Lim S. K., Park S. H. High glucose stimulates the expres39. Erythropoietin-dependent anaemia: a possible complicasion of erythropoietin in rat glomerular epithelial cells // Lab.

tion of diabetic neuropathy / S. Hadjadj, F. Torremocha, A. Fanelli Anim. Res. 2011. Vol. 27, 9. P. 245250.

[et al.] // Diabetes Metab. 2001. Vol. 27, 6. P. 383385.

21. Raupp D., Vogt C., Dreyhaupt J., Hasslacher C. Influ40. Influence of blood pressure profile on erythropoietin ence of metabolic control on hemoglobin level in type 1 diabetic levels in diabetics / H. Mayaudon, O. Dupuy, M. Dolz [et al.] // patients with nephropathy // Med. Klin. (Munich). 2008. Vol. 103, Arch. Mal. Coeur. Vaiss. 2002. Vol. 95, 78. P. 743746.

4. P. 185189.

41. Zukowska-Szczechowska E., Tomaszewski M., Sed22. Bondar I. A., Klimontov V. V., Nadeev A. P. Mochevaja kowska A., Grzeszczak W. Erythropoietin administration in diajekskrecija provospalitelnyh citokinov i transformirujuwego faktobetic patients // Przegl. Lek. 2003. Vol. 60, 8. P. 532535.

ra rosta- na rannih stadijah diabeticheskoj nefropatii // Ter. arhiv.

42. Winkler A. S., Landau S., Watkins P. J. Erythropoietin 2008. 1. S. 5256.

treatment of postural hypotension in anemic type I diabetic pa23. Erythropoietin prevents reactive oxygen species gentients with autonomic neuropathy: a case study of four patients // eration and renal tubular cell apoptosis at high glucose levDiabetes Care. 2001. Vol. 24, 6. P. 11211123.

el / J. Dang, R. Jia, y. Tu [et al.] // Biomed. Pharmacother. 2010.

43. Erythropoietin both protects from and reverses experiVol. 64, 12. P. 681685.

mental diabetic neuropathy / R. Bianchi, B. Buyukakilli, M. Brines 24. Erythropoietin prevents diabetes-induced podocyte dam[et al.] // PNAS. 2004. Vol. 101, 1. P. 823828.

age / M. Schiffer, J. K. Park, I. Tossidou [et al.] // Kidney Blood 44. Erythropoietin during hypoglycaemia in type 1 diabetes:

Press Res. 2008. Vol. 31, 6. P. 411415.

relation to basal rennin-angiotensin system activity and cogni25. Effect of erythropoietin on urinary liver-type fattytive function / P. L. Kristensen, T. Hoi-Hansen, N. V. Olsen [et al.] acid-binding protein in patients with chronic renal failure // Diabetes Research and Clinical Practice. 2009. Vol. 85, 7.

and anemia / T. Nakamura, T. Sugaya, y. Kawagoe [et al.] // P. 7584.

Amer. J. Nephrol. 2006. Vol. 26. P. 276280.

45. Choi D., Retnakaran R., Woo M. The extra-hematopoietic 26. The continuous erythropoietin receptor activator affects role of erythropoietin in diabetes mellitus // Curr. Diabetes Rev.

different pathways of diabetic renal injury / J. Menne, J. K. Park, 2011. Vol. 7, 7. P. 284290.

N. Shushakova [et al.] // J. Amer. Soc. Nephrol. 2007. Vol. 18.

46. Erythropoietin protects against diabetes through direct P. 20462053.

effects on pancreatic beta cells / D. Choi, S. A. Schroer, S. y. Lu 27. Garcia-Ramirez M., Hernandez C., Simo R. Expression [et al.] // J. Exp. Med. 2010. Vol. 207. P. 28312842.

of Erythropoietin and Its Receptor in the Human Retina: a com- 47. Improved Glycemic Control in Diabetic Patients Treated parative study of diabetic and nondiabetic subjects // Diabetes with Recombinant Human Erythropoietin / O. Katz, N. Golishevski, Care. 2008. Vol. 31, . 6. P. 11891194. H. S. Oster [et al.] // Blood. 2006. Vol. 108, 11. P. 42284229.

28. Erythropoietin Is Highly Elevated in Vitreous Fluid of 48. Erythropoietin treatment leads to reduced blood glucose Patients With Proliferative Diabetic Retinopathy / y. Katsura, levels and body mass: insights from murine models / O. Katz, T. Okano, K. Matsuno [et al.] // Diabetes Care. 2005. Vol. 28, M. Stuible, N. Golishevski [et al.] // J. Endocrinol. 2010. Vol. 205, 9. P. 22522254. 4. P. 8795.

Saratov Journal of Medical Scientific Research. 2012. Vol. 8, 1.

Pages:     | 1 | 2 ||



2011 www.dissers.ru -

, .
, , , , 1-2 .